ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681645 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681645; 2) Community: the network communities that were significantly associated with the response to NSC 681645; 3) Molecule: the relationships between components within communities and NSC 681645; 4) MDR: the compounds that were significantly associated with the NSC 681645.

NSC Compound Enrichment Correlation
NSC 726861 6-(5-tetrahydropyranylossi-1-pentynyl)-2(2H)-pyranone 0.0355196177493895 0.14400362
NSC 72942 DL-Noformicin 0.0355196177493895 0.029524661
NSC 734872 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.0355196177493895 0.63843827
NSC 740475 Null 0.0355196177493895 0.72834395
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0355196177493895 0.40629998
NSC 750285 DP1 0.0355196177493895 0.70319624
NSC 753203 N-(2-(4-(6-(4-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-4-methoxybenzamide 0.0355196177493895 0.17609993
NSC 80141 Null 0.0355196177493895 0.01780244
NSC 106442 Null 0.03551961774939 0.11448502
NSC 16166 Azure B bromide 0.03551961774939 0.11752262
Total:67  Current:47    [First] [Prev] [Next] [Last]